FdaApplication
ANDA 213913
Identifiers
- fda_app_no: ANDA213913
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2024-06-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPOPROSTENOL SODIUM | EPOPROSTENOL SODIUM | EQ 1.5MG BASE/VIAL | INJECTABLE;INJECTION |
| EPOPROSTENOL SODIUM | EPOPROSTENOL SODIUM | EQ 0.5MG BASE/VIAL | INJECTABLE;INJECTION |
2 products